Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

01548 Genscript Biotech Corporation

17.320
-0.800-4.42%
Closed 10/06 16:08 CCT
High
18.320
Open
18.320
Turnover
26.74M
Low
17.280
Pre Close
18.120
Volume
1.52M
Market Cap
36.61B
P/E(TTM)
Loss
52wk High
42.500
Shares
2.11B
P/E(Static)
Loss
52wk Low
16.300
Float Cap
36.61B
Bid/Ask %
22.87%
Historical High
43.400
Shs Float
2.11B
Volume Ratio
0.37
Historical Low
1.058
Dividend TTM
--
Div Yield TTM
--
P/B
6.16
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.07%
Amplitude
5.74%
Avg Price
17.572
Lot Size
2000
Float Cap
36.61B
Bid/Ask %
22.87%
Historical High
43.400
Shs Float
2.11B
Volume Ratio
0.37
Historical Low
1.058
Dividend TTM
--
P/B
6.16
Dividend LFY
--
Turnover Ratio
0.07%
Amplitude
5.74%
Avg Price
17.572
Lot Size
2000
Price Forecast

No Data

News

Comment

Company Overview More
Kingsley Biotechnology Co., Ltd. is a Hong Kong investment holding company mainly engaged in bioscience research and related business. The company operates through four major divisions. The Life Sciences Research Services Division includes gene and peptide synthesis, DNA and nucleic acid primer synthesis, deoxyribonucleic acid sequencing, customized antibody services, protein expression and stable cell line production. The preclinical drug development service division includes protein and antibody engineering, in vitro efficacy research and in vivo efficacy research. The Life Science Research Catalog Product Division provides antibodies, recombinant proteins, protein separation and analysis instruments, molecular biological reagents, peptides, biochemical products and stable cell lines. Industrial synthetic biological products division develops and produces industrial enzymes.
CEO: Jiange Meng
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...